908 Devices Inc. Reports $56.2 Million Revenue for Fiscal Year 2025, Driven by Product Launches

908 Devices Inc. reported a total revenue of $56.2 million for the fiscal year ending December 31, 2025, marking an increase of 18% from $47.7 million in 2024. The growth was primarily driven by a 22% rise in product revenue, which reached $43.3 million, largely attributed to the successful launch of new FTIR products, including the VipIR and XplorIR devices. However, the company also faced challenges, with a decrease in revenue from its MX908 handheld devices, which fell by $2.1 million due to fewer placements. The company incurred a net loss from continuing operations of $33.3 million, an improvement from the $53.1 million loss reported in the previous year.

In terms of strategic developments, 908 Devices completed the acquisition of CAM2 Technologies, LLC (d/b/a RedWave Technology) in April 2024, enhancing its portfolio of handheld chemical analysis devices. The acquisition was valued at $45 million in cash and included the issuance of shares. Additionally, the company divested its Desktop Portfolio to Repligen Corporation in March 2025, resulting in a gain of $55.9 million, which was classified under discontinued operations. This divestiture reflects a strategic shift aimed at focusing on core product offerings and improving operational efficiencies.

Operationally, 908 Devices has expanded its customer base to over 700 clients, including various government agencies, and has sold more than 3,700 handheld devices since its inception. The company reported a significant increase in its installed base, with cumulative product placements rising to 3,736 devices by the end of 2025. The company also noted that recurring revenue from consumables and services accounted for 35% of total revenue, indicating a growing reliance on this revenue stream as the installed base expands.

The company’s financial health remains a concern, as it continues to operate at a loss, with an accumulated deficit of $223.3 million as of December 31, 2025. Despite this, 908 Devices believes its existing cash and cash equivalents, totaling $70.5 million, will be sufficient to fund operations for at least the next 12 months. The company is actively monitoring macroeconomic conditions, including inflation and interest rates, which could impact customer spending and overall business performance.

Looking ahead, 908 Devices aims to drive growth through increased sales efforts both domestically and internationally, while continuing to enhance its product offerings. The company is also focused on managing its operational costs and improving its gross profit margins, which decreased slightly to 50.5% in 2025 from 51.3% in 2024. The management remains optimistic about the long-term potential of its products and services, despite the ongoing challenges in achieving profitability.